Koers DanDrit Biotech USA Inc OTC Bulletin Board
Aandelen
US2360781015
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 34,41 mln. 32,08 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -113 mln. -105 mln. | Nettowinst (verlies) 2023 | -39 mln. -36,35 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 1,99 mln. 1,85 mln. | Nettoschuld 2023 | 3,9 mln. 3,64 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-0,89
x | K/w-verhouding 2023 |
-0,8
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 73,77% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mark Dybul
CEO | Chief Executive Officer | 60 | 23-01-18 |
Lester Russell
CTO | Chief Tech/Sci/R&D Officer | - | 21-08-23 |
Greg Duczynski
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gregg Alton
BRD | Director/Board Member | 58 | 01-01-20 |
Avram Miller
BRD | Director/Board Member | - | 11-10-23 |
James Sapirstein
BRD | Director/Board Member | 63 | 06-03-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,65% | 104 mld. | |
+6,75% | 97,47 mld. | |
+5,71% | 22,25 mld. | |
-12,60% | 21,68 mld. | |
-9,70% | 18,2 mld. | |
-39,98% | 17,02 mld. | |
-10,17% | 16,36 mld. | |
+6,12% | 14,39 mld. | |
+35,47% | 12,37 mld. |
- Beurs
- Aandelen
- Koers RENB
- Koers